Jong-Hyuk Chung

Jong-Hyuk Chung

Auto-generated profile, based on publicly available information

Jong-Hyuk Chung

Department of Periodontology, Kyung Hee University College of Dentistry, Periodontal-Implant Clinical Research Institute, Kyung Hee University Medical Center, Seoul, Korea

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2013 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
ATAndrei D Taut
Andrei D Taut
QJQiming Jin
Qiming Jin
JCJong-Hyuk Chung
Jong-Hyuk Chung
Pablo Galindo-MorenoPablo Galindo-Moreno
Pablo Galindo-Moreno
EYErica S Yi
Erica S Yi
WGWilliam V Giannobile
William V Giannobile
: The reconstruction of large osseous defects due to periodontitis is a challenge in regenerative therapy. Sclerostin, secreted by osteocytes, is a key physiological inhibitor of osteogenesis. Pharmacologic inhibition of sclerostin using sclerostin-neutralizing monoclonal antibody (Scl-Ab) thus increases bone formation, bone mass and bone strength in models of osteopenia and fracture repair. This study assessed the therapeutic potential of Scl-Ab to stimulate alveolar bone regeneration following experimental periodontitis (EP). Ligature-induced EP was induced in rats to generate localized alveolar bone defects. Following 4 weeks of disease induction, Scl-Ab (+EP) or vehicle (+/− EP) were systemically delivered, twice weekly for up to 6 wks to determine the ability of Scl-Ab to regenerate bone around tooth-supporting osseous defects. 3 and 6 wks after the initiation of Scl-Ab or vehicle treatment, femur and maxillary jawbones were harvested for histology, histomorphometry, and micro-computed tomography (micro-CT) of linear alveolar bone loss (ABL) and volumetric measures of bone support, including bone volume fraction (BVF) and tissue mineral density (TMD). Serum was analyzed to examine bone turnover markers during disease and regenerative therapy. Vehicle + EP animals exhibited maxillary bone loss (BVF, TMD and ABL) at ligature removal and thereafter. 6 weeks of Scl-Ab significantly improved maxillary bone healing, as measured by BVF, TMD and ABL, when compared to vehicle + EP. After 6 weeks of treatment, BVF and TMD values in the Scl-Ab + EP group were similar to those of healthy controls. Serum analysis demonstrated higher levels of bone formation markers osteocalcin and PINP in Scl-Ab treatment groups. Scl-Ab restored alveolar bone mass following experimental periodontitis. These findings warrant further exploration of Scl-Ab therapy in this and other oral bone defect disease scenarios. © 2013 American Society for Bone and Mineral Research.

8 December 2011 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
SKSo‐Jin Kang
So‐Jin Kang
SSSeung-Il Shin
Seung-Il Shin
YHYeek Herr
Yeek Herr
YKYoung‐Hyuk Kwon
Young‐Hyuk Kwon
GKGyu‐Tae Kim
Gyu‐Tae Kim
JCJong‐Hyuk Chung
Jong‐Hyuk Chung

28 November 2012 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SLSun‐Kyung Lee
Sun‐Kyung Lee
JCJong‐Hyuk Chung
Jong‐Hyuk Chung
SCSung Chul Choi
Sung Chul Choi
QAQ‐Schick Auh
Q‐Schick Auh
YLYoung‐Man Lee
Young‐Man Lee
EKEun-Cheol Kim
Eun-Cheol Kim

1 January 2021 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
HLHyun-Chang Lim
Hyun-Chang Lim
Sangyup KimSangyup Kim
Sangyup Kim
DKDo-Hyup Kim
Do-Hyup Kim
YHYeek Herr
Yeek Herr
JCJong-Hyuk Chung
Jong-Hyuk Chung
SSSeung-Il Shin
Seung-Il Shin
Lim HC, et al. J Periodontal Implant Sci. 2021 May;51:e22. https://doi.org/10.5051/jpis.2007220361

1 July 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JPJin-Woo Park
Jin-Woo Park
THTakao Hanawa
Takao Hanawa
JCJong-Hyuk Chung
Jong-Hyuk Chung
Purpose: Calcium (Ca) and magnesium (Mg) ions have been used as promising bioactive ions in the surface chemistry modification of titanium (Ti) bone implants to increase bone regeneration capacity. However, it is not clear which (Ca or Mg) plays the more important role in the early osteogenic differentiation of mesenchymal stem cells (MSCs) when applied to the surface of commercially available microstructured Ti implants. This study investigated the relative effect of these two ions on the early osteogenic functionality of primary mouse bone marrow MSCs in order to obtain insights into the surface design of Ti implants with enhanced early osteogenic capacity. Methods and results: Wet chemical treatment was performed to modify a microrough Ti implant surface using Ca or Mg ions. Both the Ca and Mg-incorporated surfaces accelerated early cellular events and the subsequent osteogenic differentiation of MSCs compared with an unmodified microrough Ti surface. Surface Mg modification exhibited a more potent osteoblast differentiation-promoting effect than the Ca modification. Surface Mg incorporation markedly inhibited the phosphorylation of β-catenin. Conclusion: These results indicate that alteration of the surface chemistry of microstructured Ti implants by wet chemical treatment with Mg ions exerts a more effect on promoting the early osteogenic differentiation of MSCs than Ca ions by enhancing early cellular functions, including focal adhesion development and stabilization of intracellular β-catenin.